![[current-page:title] logo](/sites/default/files/styles/logo/public/default_images/_no-logo.png?itok=8OH0tuUw){kind=logo}
Address
KBC Private Equity NV
12 Havenlaan
1080 Brussels
Belgium
Phone
Website
Recent investment activity
KANDO id: 4033
Corporate information
Registration country
Funding rounds
Investment activity status
Active investor
Selected investments
Displaying 1 - 6 of 6| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
arGEN-X BV | Innovation-driven biopharmaceutical company. | Series A | |||
|
|
Metabolex Inc | Focuses on the discovery and development of novel therapeutics for the treatment of diabetes. | N/A | |||
|
|
Metabolex Inc | Focuses on the discovery and development of novel therapeutics for the treatment of diabetes. | Series D | |||
|
|
Athersys Inc | Develops therapeutic products to treat significant and life-threatening diseases. | N/A | |||
|
|
Ceres Inc | Plant genomics biotechnology company | N/A | |||
|
|
elbion AG | N/A |
Team
| Employee | Position | |||
|---|---|---|---|---|
| Philippe de Vicq | [email protected] | |||
| Floris Vansina | [email protected] | |||
| Ruth Devenyns |